Vaccination with a ZNF2oe Strain of Cryptococcus Provides Long-Lasting Protection against Cryptococcosis and Is Effective in Immunocompromised Hosts

T Pham, Y Li, W Watford, X Lin - Infection and Immunity, 2023 - Am Soc Microbiol
Systemic cryptococcosis is fatal without treatment. Even with the current antifungal therapies,
this disease kills 180,000 of 225,000 infected people annually. Exposure to the causative …

Immunoprotection against cryptococcosis offered by znf2 depends on capsule and the hyphal morphology

J Lin, T Pham, K Hipsher, N Glueck, Y Fan, X Lin - MBio, 2022 - Am Soc Microbiol
Systemic cryptococcosis is fatal without treatment. Globally, this disease kills 180,000 of the
225,000 infected people each year, even with the use of antifungal therapies. Currently …

Induction of Broad-Spectrum Protective Immunity against Disparate Cryptococcus Serotypes

MCC Van Dyke, AK Chaturvedi, SE Hardison… - Frontiers in …, 2017 - frontiersin.org
Cryptococcosis is a fungal disease caused by multiple Cryptococcus serotypes; particularly
C. neoformans (serotypes A and D) and C. gattii (serotypes B and C). To date, there is no …

A call to arms: quest for a cryptococcal vaccine

MCC Van Dyke, FL Wormley - Trends in microbiology, 2018 - cell.com
Cryptococcosis remains a significant cause of morbidity and mortality world-wide,
particularly among AIDS patients. Yet, to date, there are no licensed vaccines clinically …

[PDF][PDF] Vaccination with recombinant Cryptococcus proteins in glucan particles protects mice against cryptococcosis in a manner dependent upon mouse strain and …

CA Specht, CK Lee, H Huang, MM Hester, J Liu… - 2017 - core.ac.uk
Development of a vaccine to protect against cryptococcosis is a priority given the enormous
global burden of disease in at-risk individuals. Using glucan particles (GPs) as a delivery …

Promising whole‐cell vaccines against cryptococcosis

K Ueno, S Tsuge, K Shimizu… - Microbiology and …, 2023 - Wiley Online Library
Cryptococcosis is a mycosis caused by Cryptococcus neoformans and C. gattii species
complexes. Although this infection is potentially lethal, no prophylactic vaccine is yet …

Three Models of Vaccination Strategies Against Cryptococcosis in Immunocompromised Hosts Using Heat-Killed Cryptococcus neoformans Δsgl1

TG Normile, M Del Poeta - Frontiers in Immunology, 2022 - frontiersin.org
Vaccines are one of the greatest medical accomplishments to date, yet no fungal vaccines
are currently available in humans mainly because opportunistic mycoses generally occur …

Towards a vaccine for Cryptococcus neoformans: principles and caveats

K Datta, L Pirofski - FEMS yeast research, 2006 - academic.oup.com
In the Damage-response framework of microbial pathogenesis, infectious diseases are one
outcome of a host-microorganism interaction in a susceptible host. In cryptococcal disease …

Vaccine and immunotherapeutic approaches for the prevention of cryptococcosis: lessons learned from animal models

CR Hole, FL Wormley Jr - Frontiers in microbiology, 2012 - frontiersin.org
Cryptococcus neoformans and C. gattii, the predominant etiological agents of
cryptococcosis, can cause life-threatening infections of the central nervous system in …

Vaccination with Recombinant Cryptococcus Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and …

CA Specht, CK Lee, H Huang, MM Hester, J Liu… - MBio, 2017 - Am Soc Microbiol
Development of a vaccine to protect against cryptococcosis is a priority given the enormous
global burden of disease in at-risk individuals. Using glucan particles (GPs) as a delivery …